Agenus  
Agenus公司是一家致力于开发创新的免疫系统激活疗法以治疗癌症和传染性疾病的生物技术企业。

Agenus Inc. is a biotechnology company developing treatments for cancers and infectious diseases. The company has multiple immunotherapeutic products in its clinical development portfolio. Through partnerships involving its QS-21 Stimulon adjuvant, there are 21 candidates in clinical development. These include four late stage Phase 3 programs with GlaxoSmithKline.